Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110419

The Binding of Human Immunoglobulin G1 Monomer and Small, Covalently Cross-Linked Polymers of Immunoglobulin G1 to Human Peripheral Blood Monocytes and Polymorphonuclear Leukocytes

Roger J. Kurlander and Janet Batker

Medical Research Service, Durham Veterans Administration Hospital, Durham, North Carolina, 27705

Myrtle Bell Lane Laboratory, Department of Medicine, Duke University Medical Center, Durham North Carolina, 27710

Find articles by Kurlander, R. in: PubMed | Google Scholar

Medical Research Service, Durham Veterans Administration Hospital, Durham, North Carolina, 27705

Myrtle Bell Lane Laboratory, Department of Medicine, Duke University Medical Center, Durham North Carolina, 27710

Find articles by Batker, J. in: PubMed | Google Scholar

Published January 1, 1982 - More info

Published in Volume 69, Issue 1 on January 1, 1982
J Clin Invest. 1982;69(1):1–8. https://doi.org/10.1172/JCI110419.
© 1982 The American Society for Clinical Investigation
Published January 1, 1982 - Version history
View PDF
Abstract

Covalently cross-linked dimers and oligomers composed of 2-4 subunits of monoclonal human IgG1 were prepared by incubation of purified monomeric IgG1 with glutaraldehyde followed by gelfiltration chromatography. Monomers, dimers, and oligomers then were labeled with 125I and used to compare the binding properties of IgG Fc receptors on human peripheral blood monocytes and polymorphonuclear leukocytes (PMN). Binding of IgG1 to monocytes at 37°C and of IgG1 polymers to PMN at 4°C could be readily measured and were found to be reversible and saturable. Scatchard plots of binding were linear in each instance. Monocytes bound a mean of 20,200±6,800 molecules/cell of IgG1 monomer at saturation and comparable amounts of dimer or oligomer. The mean association constant (Ka) for binding of IgG1 monomer to monocytes was 8.6 × 108M−1 and the Ka for binding of dimer and oligomer were three-to fivefold greater.

In contrast, PMN bound a mean of 460,000±130,000 molecules of IgG1 dimer at saturation and comparable amounts of oligomer. The Ka of binding in both cases was 100-1,000-fold lower than the Ka for binding of the same preparations to monocytes.

Binding of labeled IgG1 to both cell types was more potently inhibited by unlabeled IgG1 and IgG3 than by IgG4 or IgG2. Binding of labeled polymers of IgG1 to monocytes was 10-100-fold more easily inhibited by monomeric IgG1 than was binding to PMN. Thus, there are significant quantitative and qualitative differences between the binding properties of Fc receptors present on monocytes and PMN.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1
page 1
icon of scanned page 2
page 2
icon of scanned page 3
page 3
icon of scanned page 4
page 4
icon of scanned page 5
page 5
icon of scanned page 6
page 6
icon of scanned page 7
page 7
icon of scanned page 8
page 8
Version history
  • Version 1 (January 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts